WIL Research has acquired Ricerca Biosciences’ pharmaceutical services business in Lyon, France. The 18,000-sq.-m. facility expands WIL Research’s service offerings in Europe and adds to its nonclinical safety assessment capability, as well as expands its portfolio of specialty services. The site, renamed WIL Research Europe – Lyon, will retain its approximately 280 employees. Stéphane Bulle, managing director of the facility, will continue to lead the site with his current senior leadersh...